Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications

Harrison, Stephanie L ORCID: 0000-0002-8846-0946, Buckley, Benjamin JR ORCID: 0000-0002-1479-8872, Lane, Deirdre A ORCID: 0000-0002-5604-9378, Underhill, Paula and Lip, Gregory YH (2021) Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications. PHARMACOLOGICAL RESEARCH, 167.

Text Antipsychotic use dementia and COVID_12Feb2021.doc - Author Accepted Manuscript Download (211kB)

Item Type:	Article
Uncontrolled Keywords:	Dementia, Alzheimer's disease, Antipsychotics, COVID-19, Mortality
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User:	Symplectic Admin
Date Deposited:	25 Aug 2021 09:49
Last Modified:	18 Jan 2023 21:32
DOI:	10.1016/j.phrs.2021.105534
Related URLs:	Author
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3134604

Available Versions of this Item

• Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications. (deposited 25 Aug 2021 09:49) [Currently Displayed]
  • Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications. (deposited 13 Sep 2021 07:39)